Big Data Institute, University of Oxford, Old Road Campus, Headington, Oxford, UK.
Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.
Nat Commun. 2020 Oct 8;11(1):5070. doi: 10.1038/s41467-020-18843-5.
The evolutionary progression from primary to metastatic prostate cancer is largely uncharted, and the implications for liquid biopsy are unexplored. We infer detailed reconstructions of tumor phylogenies in ten prostate cancer patients with fatal disease, and investigate them in conjunction with histopathology and tumor DNA extracted from blood and cerebrospinal fluid. Substantial evolution occurs within the prostate, resulting in branching into multiple spatially intermixed lineages. One dominant lineage emerges that initiates and drives systemic metastasis, where polyclonal seeding between sites is common. Routes to metastasis differ between patients, and likely genetic drivers of metastasis distinguish the metastatic lineage from the lineage that remains confined to the prostate within each patient. Body fluids capture features of the dominant lineage, and subclonal expansions that occur in the metastatic phase are non-uniformly represented. Cerebrospinal fluid analysis reveals lineages not detected in blood-borne DNA, suggesting possible clinical utility.
从原发性前列腺癌到转移性前列腺癌的进化过程在很大程度上是未知的,液体活检的意义也尚未被探索。我们对 10 名患有致命疾病的前列腺癌患者的肿瘤进化树进行了详细的重建,并结合组织病理学和从血液及脑脊液中提取的肿瘤 DNA 进行了研究。在前列腺内发生了大量的进化,导致分支为多个空间混合的谱系。一个主要的谱系出现,启动并驱动全身性转移,其中常见的是多克隆在不同部位间播种。转移的途径在患者之间存在差异,并且转移谱系的遗传驱动因素可能与每个患者中仍局限于前列腺的谱系不同。体液可捕获优势谱系的特征,并且在转移阶段发生的亚克隆扩增是非均匀表达的。脑脊液分析揭示了在血液源性 DNA 中未检测到的谱系,这表明可能具有临床应用价值。